← Open Payments lookup

LAWRENCE OGBECHIE: Open Payments

NPI 1003868217 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,883 in 82 payments from 11 companies in 2025. Trend: 2023 $1,887 · 2024 $1,544 · 2025 $1,883

Food & beverage: $1,883
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.23$640
ABBVIE INC.18$267
Neurocrine BioSciences, Inc.10$219
Teva Pharmaceuticals USA, Inc.3$160
Otsuka America Pharmaceutical, Inc.7$146
Janssen Pharmaceuticals, Inc4$124
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$99
E.R. Squibb & Sons, L.L.C.4$70
Alkermes, Inc.3$58
Lundbeck LLC2$53

Products named: FANAPT, VRAYLAR, INGREZZA, AUSTEDO XR, REXULTI, INVEGA SUSTENNA, CAPLYTA, COBENFY.

Industry payments across CA — which companies pay providers there.